T-Cell Engagers - Modern Immune-Based Therapies for Multiple Myeloma.

Mailankody, Sham; Landgren, Ola

Mailankody, Sham; Landgren, Ola.

Mailankody S; From the Myeloma and Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (S.M.); and the Division of Myeloma, Sylvester Comprehensive Cancer Center, University of Miami, Miami (O.L.).
Landgren O; From the Myeloma and Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (S.M.); and the Division of Myeloma, Sylvester Comprehensive Cancer Center, University of Miami, Miami (O.L.).

N Engl J Med ; 387(6): 558-561, 2022 08 11.

Article in English | MEDLINE | ID: covidwho-1991729

Subject(s)

Immunotherapy; Multiple Myeloma; T-Lymphocytes; Humans; Immunotherapy/methods; Immunotherapy/trends; Immunotherapy, Adoptive; Multiple Myeloma/drug therapy; Multiple Myeloma/immunology; Multiple Myeloma/therapy; T-Lymphocytes/immunology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: T-Lymphocytes / Immunotherapy / Multiple Myeloma Limits: Humans Language: English Journal: N Engl J Med Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google